Skip to main content
Caplight Logo









Tentarix Biotherapeutics

Tentarix Biotherapeutics

Private
San Diego, CaliforniaHealthcare & Life Scienceshttps://www.tentarix.com/

Last Round

Series B

Sep 6, 2023

Total Funding Raised

$85M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Tentarix Biotherapeutics is a biotechnology company that develops conditionally active, multispecific biologic therapies for oncology and autoimmune diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

multi-specific antibodybiologics discoverybispecific antibodyantibody engineeringconditionally active biologicsdrug discovery platformtherapeutic antibodyoncology therapeuticsimmunologybiotech platformprotein engineeringbiotech discovery enginebiotech R&Dbiotech startupdrug discovery partner

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Tentarix Biotherapeutics Comparables

Compare Tentarix Biotherapeutics with similar companies based on industry and business-model similarity.

Tentarix Biotherapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Bonum Therapeutics
87%
Invenra
85%
Amberstone Biosciences
83%

Tentarix Biotherapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BSep 6, 2023
Series AOct 14, 2021

Key People

Founding team and executive leadership

Andy Kidd

Chief Executive Officer

Executive Team

Tentarix Biotherapeutics Investors

Notable investors and investment history

Tentarix Biotherapeutics investors
InvestorRounds
Amplitude VenturesSeries B
Versant VenturesSeries B, Series A
Samsara BioCapitalSeries B, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 22, 2026

    Ongoing partnered programs disclosed with Gilead and AbbVie.

  • Sep 6, 2023

    $35M round led by Amplitude Ventures.

Tentarix Biotherapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Tentarix Biotherapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Tentarix Biotherapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Diego, California
Employee Range57
Year Founded2020
Last FundingSep 6, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?